Next Article in Journal
Stress Degradation Studies on Varenicline Tartrate and Development of a Validated Stability-Indicating HPLC Method
Previous Article in Journal
Pharmacological and Phytochemical Appraisal of Selected Medicinal Plants from Jordan with Claimed Antidiabetic Activities
 
 
Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2016). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Isolation and Characterisation of Degradation Impurities in the Cefazolin Sodium Drug Substance

by
Balasubramanian SIVAKUMAR
*,
Kannabiran PARTHASARATHY
,
Raman MURUGAN
,
Ramajeyabalan JEYASUDHA
,
Saravanan MURUGAN
and
Rajendira JANARDHAN SARANGHDAR
Orchid Chemicals and Pharmaceuticals Limited, Research and Development Centre, Sozhanganallur, Chennai 600 119, Tamilnadu, India
*
Author to whom correspondence should be addressed.
Sci. Pharm. 2013, 81(4), 933-950; https://doi.org/10.3797/scipharm.1304-14
Submission received: 15 April 2013 / Accepted: 4 June 2013 / Published: 4 June 2013

Abstract

Two unknown impurities were detected in the cefazolin sodium bulk drug substance using gradient reversed-phase high-performance liquid chromate-graphy (HPLC). These impurities were isolated by preparative HPLC and characterized by using spectroscopic techniques like LC-MS, LC-MS/MS, 1D, 2D NMR, and FT-IR. Based on the spectral data, the impurities have been characterized as N-(2,2-dihydroxyethyl)-2-(1H-tetrazol-1-yl)acetamide (Impu rity-I) and 2-{carboxy[(1H-tetrazol-1-ylacetyl)amino]methyl}-5-methylidene-5,6-dihydro-2H-1,3-thiazine-4-carboxylic acid (Impurity-II). The structures of these impurities were also established unambiguously by co-injection into HPLC to confirm the retention time. To the best of our knowledge, these two impurities were not reported elsewhere.
Keywords: Cefazolin sodium; Degradation Impurities; LC-MS/MS; NMR; β-Lactam Cefazolin sodium; Degradation Impurities; LC-MS/MS; NMR; β-Lactam

Share and Cite

MDPI and ACS Style

SIVAKUMAR, B.; PARTHASARATHY, K.; MURUGAN, R.; JEYASUDHA, R.; MURUGAN, S.; SARANGHDAR, R.J. Isolation and Characterisation of Degradation Impurities in the Cefazolin Sodium Drug Substance. Sci. Pharm. 2013, 81, 933-950. https://doi.org/10.3797/scipharm.1304-14

AMA Style

SIVAKUMAR B, PARTHASARATHY K, MURUGAN R, JEYASUDHA R, MURUGAN S, SARANGHDAR RJ. Isolation and Characterisation of Degradation Impurities in the Cefazolin Sodium Drug Substance. Scientia Pharmaceutica. 2013; 81(4):933-950. https://doi.org/10.3797/scipharm.1304-14

Chicago/Turabian Style

SIVAKUMAR, Balasubramanian, Kannabiran PARTHASARATHY, Raman MURUGAN, Ramajeyabalan JEYASUDHA, Saravanan MURUGAN, and Rajendira JANARDHAN SARANGHDAR. 2013. "Isolation and Characterisation of Degradation Impurities in the Cefazolin Sodium Drug Substance" Scientia Pharmaceutica 81, no. 4: 933-950. https://doi.org/10.3797/scipharm.1304-14

APA Style

SIVAKUMAR, B., PARTHASARATHY, K., MURUGAN, R., JEYASUDHA, R., MURUGAN, S., & SARANGHDAR, R. J. (2013). Isolation and Characterisation of Degradation Impurities in the Cefazolin Sodium Drug Substance. Scientia Pharmaceutica, 81(4), 933-950. https://doi.org/10.3797/scipharm.1304-14

Article Metrics

Back to TopTop